DFE Pharma opens new Centre of Excellence in Hyderabad

 DFE Pharma opens new Centre of Excellence in Hyderabad

 DFE Pharma, the Germany-based pharma – and nutraceutical excipient solutions provider, recently opened its new Centre of Excellence –‘Closer to the Formulator’ (C2F) - in Hyderabad. The inauguration was attended by Mr. K.T. Rama Rao, Minister for IT, Industries & Commerce, Municipal Administration & Urban Departments of the Telangana government along with Mr. Jayesh Ranjan, IAS, Principal Secretary, Industries and Commerce, Government of Telangana, Mr. Shakthi Nagappan, Director (Life Sciences & Pharma), Government of Telangana and DFE Pharma’s leadership team and senior representatives of leading pharmaceutical companies. The centre is based in Genome Valley, the largest pharma and life sciences hub in Asia. Speaking on the occasion, Mr. Rama Rao, said, “I fi rmly believe that C2F will further strengthen the potential for growth and support offered by Genome Valley. The Government of Telangana will work with DFE Pharma to ensure that life sciences companies in the state leverage from this facility.” DFE Pharma said the C2F will help pharmaceutical companies to shorten the time from concept to fi nished commercial product through its expertise in all phases of pharmaceutical development. The services offered by the new centre mainly focus on oral solid dosage (OSD) forms and comprise a range of pre-registration work including development, scale-up, and technology transfer. The capabilities also include effi ciency projects like conversions from wet granulation to direct compression. The centre works with active pharmaceutical ingredients (APIs), including innovative concepts as model APIs; and with a broad portfolio of all categories of excipients and their different grades. 

Mr. Martti Hedman, CEO of DFE Pharma commented, “With our C2F centre, based at a prime location in the pharma and life sciences hub Genome Valley, we can help pharmaceutical and nutraceutical companies progress their projects faster and further. Through our capabilities, we not only support our customers to develop high-quality products but also improve their effi - ciencies.” “We aim to closely work with our customers to help them develop new ideas, together we address their challenges using our expertise in the latest pharmaceutical trends” explained Dr. Anilkumar Gandhi, Director of the C2F Centre of Excellence. “The capabilities offered through this centre can reduce the time to launch a product, without compromising quality, while reducing the number of development assays and therefore decreasing formulation spending,” he added.